AzTrials
AzTrials

Spinal FusionNCT01742936

Point of Care Testing in Pediatric Patients Undergoing Major Surgery

A study testing CoaguChek and Hospital Laboratory in people with Spinal Fusion and Cardiopulmonary Bypass, run by Nationwide Children's Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current study proposes to investigate Point of Care Testing (POCT) (Coagcheck®) and compare obtained results versus standard laboratory coagulation parameters prothrombin time (PT) and partial thromboplastin time (PTT). The time difference in obtaining the two results will also be examined. Read more about this study

Who is it for?
Ages 2 to 18 years
Conditions the study is for
Spinal Fusion, Cardiopulmonary Bypass
What is being tested?
CoaguChek and Hospital Laboratory
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
Feb 2013to Jan 2015
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Undergoing elective posterior spinal fusion surgery at Nationwide Children's Hospital
  • Parents willing \& able to provide informed consent
  • Child able to provide assent (if age appropriate)

Who cannot join

  • Pre-existing bleeding disorders
  • Any other circumstance which, in the opinion of the investigator, would put the patient at increased risk.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Nationwide Children's Hospital

    Columbus, Ohio, 43205

Other trials in United States

About this study

Official title: Point of Care Testing for Coagulation Function Versus Standard Laboratory Testing in Pediatric Patients Undergoing Major Surgery

The current study proposes to investigate Point of Care Testing (POCT) (Coagcheck®) and compare obtained results versus standard laboratory coagulation parameters prothrombin time (PT) and partial thromboplastin time (PTT). The time difference in obtaining the two results will also be examined. A total of 100 pediatric patients undergoing spinal surgery or cardiopulmonary bypass will be enrolled and consented per protocol. Blood samples will be obtained simultaneously tested on both the standard laboratory apparatus and the Coagcheck® device. If the two results are comparable, this could have immediate clinical application and impact in the operating room as POCT results are available within 2-3 minutes compared to 1-2 hours for standard laboratory samples.

Being tested
CoaguChek, Hospital Laboratory

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CoaguChekDevice

    Hand held coagulation monitor.

  • Hospital LaboratoryOther

    Coagulation testing done by hospital laboratory.

Study groups in NCT01742936
Study groupRoleWhat they receive
Spinal fusionExperimentalPatients undergoing a posterior spinal fusion and having clotting factors checked by both hand held CoaguChek and Hospital Laboratory.
Receives: Device: CoaguChek; Other: Hospital Laboratory
Cardiac bypassExperimentalPatients undergoing surgery requiring cardiopulmonary bypass and having clotting factors checked by both hand held CoaguChek and Hospital Laboratory.
Receives: Device: CoaguChek; Other: Hospital Laboratory

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. International Normalized Ratio (INR) on CoaguChek

    Measuring the blood's ability to clot on a handheld monitor.

    Measured: At end of surgery (an average of 2-4 hrs for cardiac bypass and 4-6 hrs. for spinal fusion)

  2. International Normalized Ratio (INR) Performed by Hospital Laboratory

    Measuring the bloods ability to clot by the hospital's reference laboratory.

    Measured: At end of surgery (an average of 2-4 hrs for cardiac bypass and 4-6 hrs. for spinal fusion)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Dec 2012 (estimated)
  2. Study startFeb 2013
  3. Primary completionJan 2015
  4. Study completionJan 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01742936
Sponsor's protocol ID
IRB12-00762
Status last verified
Jul 2016
First submitted
3 Dec 2012
Last updated
25 Aug 2016
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing CoaguChek and Hospital Laboratory in people with Spinal Fusion and Cardiopulmonary Bypass, run by Nationwide Children's Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 8 Jun 2016). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

International Normalized Ratio (INR) on CoaguChek (time frame: At end of surgery (an average of 2-4 hrs for cardiac bypass and 4-6 hrs. for spinal fusion)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in